Scilex Holding (SCLX) Equity Average (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Equity Average of -$230.9 million for Q1 2026, down 14.28% year-over-year from -$269.4 million in Q1 2025, and down 20.05% on a QoQ basis from -$192.4 million in Q4 2025.

Scilex Holding (SCLX) Equity Average (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Equity Average for 7 consecutive years, with -$230.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Equity Average fell 14.28% year-over-year to -$230.9 million; the TTM figure through Mar 2026 stood at -$230.9 million (down 14.28% YoY), while the FY2025 annual figure was -$200.2 million, down 9.53% from the prior year.
  • Equity Average came in at -$230.9 million for Q1 2026 at Scilex Holding, down from -$192.4 million in the prior quarter.
  • The five-year high for Equity Average was $23.7 million in Q1 2023, with the low at -$241.8 million in Q2 2022.
  • Average Equity Average over 5 years is -$169.6 million, with a median of -$202.1 million recorded in 2025.
  • Across the five-year window, Equity Average plunged 2824.72% in 2022 and surged 110.39% in 2023, its largest moves.
  • Year by year, Equity Average stood at -$96.6 million in 2022, then slumped by 73.75% to -$167.8 million in 2023, then decreased by 20.37% to -$202.0 million in 2024, then climbed by 4.76% to -$192.4 million in 2025, then slipped by 20.05% to -$230.9 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods registered -$230.9 million, -$192.4 million, and -$213.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 28.87 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 81.37 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -4.96 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 49.27 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 8.92 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 23.11 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 88.29 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -230.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -230.93 Mn
Dec 31, 2025 -192.36 Mn
Sep 30, 2025 -212.96 Mn
Jun 30, 2025 -230.24 Mn
Mar 31, 2025 -202.06 Mn
Dec 31, 2024 -201.98 Mn
Sep 30, 2024 -213.00 Mn
Jun 30, 2024 -202.24 Mn
Mar 31, 2024 -181.36 Mn
Dec 31, 2023 -167.80 Mn
Sep 30, 2023 -76.13 Mn
Jun 30, 2023 10.75 Mn
Mar 31, 2023 23.66 Mn
Dec 31, 2022 -96.58 Mn
Sep 30, 2022 -240.75 Mn
Jun 30, 2022 -241.83 Mn
Mar 31, 2022 -227.72 Mn
Dec 31, 2021 -116.85 Mn
Sep 30, 2021 -9.11 Mn
Jun 30, 2021 -8.27 Mn